Analysts expect Ovid Therapeutics Inc. to report revenue of 18,605.90 for Q3 26, against a range of 16,807.44 to 20,404.36. The most recent reported quarter, Q2 26, came in at 733,000.00 , in line with the 20,171.09 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 173,000.00 | 76,000.00 | 130,000.00 | 6.27 M | 132,000.00 | 718,000.00 | 0.00 | 733,000.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 119,520.48 | 212,448.64 | 49,554.59 | 107,860.42 | 215,749.33 | 87,393.98 | 58,354.66 | 21,183.44 | 20,404.36 | 96,810.80 | 33,971.59 | 211,804.55 | -1.31 M | -437,202.85 | 592,474.44 | 1.23 M | ||||||||||
| Low Estimate | 103,103.52 | 186,736.34 | 46,040.97 | 97,489.62 | 181,719.99 | 76,112.52 | 51,922.32 | 19,158.74 | 16,807.44 | 89,309.42 | 30,142.99 | 180,919.55 | -1.43 M | -503,866.31 | 533,721.90 | 1.06 M | ||||||||||
| Consensus Estimate | 111,312.00 | 199,592.49 | 47,797.78 | 102,675.02 | 198,734.66 | 81,753.25 | 55,138.49 | 20,171.09 | 18,605.90 | 93,060.11 | 32,057.29 | 196,362.05 | -1.37 M | -470,534.58 | 563,098.17 | 1.14 M |
Analysts expect Ovid Therapeutics Inc. to report earnings per share of -0.09 for Q3 26, against a range of -0.10 to -0.08. The most recent reported quarter, Q2 26, came in at -0.08, a 33.3% beat against the -0.12 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.20 | -0.13 | -0.14 | -0.06 | -0.17 | 0.06 | -0.12 | -0.08 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.21 | -0.17 | -0.12 | -0.16 | -0.14 | -0.10 | -0.10 | -0.11 | -0.08 | -0.08 | -0.08 | -0.09 | -0.10 | -0.05 | -0.11 | -0.11 | ||||||||||
| Low Estimate | -0.23 | -0.19 | -0.14 | -0.18 | -0.16 | -0.12 | -0.12 | -0.13 | -0.10 | -0.08 | -0.10 | -0.11 | -0.10 | -0.07 | -0.13 | -0.13 | ||||||||||
| Consensus Estimate | -0.22 | -0.18 | -0.13 | -0.17 | -0.15 | -0.11 | -0.11 | -0.12 | -0.09 | -0.08 | -0.09 | -0.10 | -0.10 | -0.06 | -0.12 | -0.12 |
Pull Wall Street consensus for Ovid Therapeutics Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=OVID&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "OVID", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=OVID&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();